Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Liqiang Pharmaceutical is a comprehensive pharmaceutical enterprise based in Linyi, Shandong Province, China. The company focuses on the research, development, and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. Its primary therapeutic focus areas include endocrinology, cardiovascular medicine, and anti-infectives. The product portfolio features essential medications such as metformin and gliclazide, which are produced in GMP-certified facilities. Shandong Liqiang Pharmaceutical serves both the Chinese domestic market and international clients through its chemical synthesis and formulation capabilities. The company is recognized for its commitment to quality standards and its role as a significant supplier of chemical drugs in the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Liqiang Pharmaceutical.